Testing effectiveness (Phase 2)Study completedNCT01720875What this trial is testingVorinostat, Bortezomib and Dexamethasone in Multiple Myeloma (MUKFour)Who this might be right forMultiple Myeloma University of Leeds 16
Not applicableNo Longer AvailableNCT02368301What this trial is testingExpanded Access Treatment Protocol CA204-143Who this might be right forMultiple Myeloma Bristol-Myers Squibb
Testing effectiveness (Phase 2)Looking for participantsNCT07227311What this trial is testingEvaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)Who this might be right forMultiple Myeloma GlaxoSmithKline 200
Testing effectiveness (Phase 2)Study completedNCT02113319What this trial is testingStudy to Assess Dasatinib in Patients With Core Binding Factors Acute Myelogenous LeukemiaWho this might be right forAcute Myelogenous Leukemia University Hospital, Angers 27
Testing effectiveness (Phase 2)Looking for participantsNCT04047641What this trial is testingCladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeWho this might be right forAcute Myeloid LeukemiaBlasts 20 Percent or More of Bone Marrow Nucleated CellsHigh Risk Myelodysplastic Syndrome+5 more M.D. Anderson Cancer Center 80
Not applicableLooking for participantsNCT07511829What this trial is testingWearAble Technology for Collecting Health Data in People Who Are the Transfused (WATCH Transfused) - A UK Exploratory Study to Improve Quality of Life and the Efficacy of Transfusion Supportive Care in People With Blood Cancers Undergoing TreatmentWho this might be right forMDS (Myelodysplastic Syndrome)AML (Acute Myeloid Leukemia) University of Oxford 80
Not applicableStudy completedNCT00511537What this trial is testingUnrelated Stem Cell Transplantation for Adults With Hematopoietic DisordersWho this might be right forCMLALLAML+3 more University of California, San Francisco 30
Early research (Phase 1)Study completedNCT00012207What this trial is testingBiological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Fred Hutchinson Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00448357What this trial is testingAllogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based RegimenWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more UNC Lineberger Comprehensive Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT00854945What this trial is testingStudy of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AMLWho this might be right forMyelodysplastic SyndromeAcute Myeloid Leukemia Traws Pharma, Inc. 36
Testing effectiveness (Phase 2)Looking for participantsNCT06822972What this trial is testingHCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMMWho this might be right forMultiple Myeloma in RelapseMultiple Myeloma, Refractory Duke University 27
Early research (Phase 1)Study completedNCT03236857What this trial is testingThe Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory MalignanciesWho this might be right forMalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)+2 more AbbVie 143
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390865What this trial is testingTesting MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more National Cancer Institute (NCI) 49
Early research (Phase 1)Looking for participantsNCT07439211What this trial is testingAssessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia, MyeloidLeukemiaAcute Myeloid Leukemia+1 more Jacqueline Garcia, MD 48
Early research (Phase 1)Study completedNCT03309111What this trial is testingStudy of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple MyelomaWho this might be right forRelapsed/Refractory Multiple Myeloma Ichnos Sciences SA 81
Early research (Phase 1)Looking for participantsNCT05054257What this trial is testingCART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's LymphomaWho this might be right forRelapsed or Refractory B-cell Acute Lymphoblastic LeukemiaNon-Hodgkin's Lymphoma RefractoryNon-Hodgkin's Lymphoma, Relapsed Institute of Hematology and Blood Transfusion, Czech Republic 10
Not applicableLooking for participantsNCT06111612What this trial is testingIntensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary InvolvementWho this might be right forAcute Myeloid LeukemiaMyelodysplastic NeoplasmChronic Myelomonocytic Leukemia+2 more Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Early research (Phase 1)WithdrawnNCT06007911What this trial is testingVenetoclax-Navitoclax With Cladribine-based Salvage Therapy in Patients With Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forRelapsed Adult AMLRefractory AML Medical College of Wisconsin
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439136What this trial is testingTesting Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 40
Not applicableNot Yet RecruitingNCT07717164What this trial is testingPRAISE-IR Versus CIBMTR ControlsWho this might be right forALL (Acute B-Lymphoblastic Leukemia)AML (Acute Myeloid Leukemia)MDS (Myelodysplastic Syndrome) Miltenyi Biomedicine GmbH 51